510(k) Report

510(k) · Cleared

Cleared

BreatheSuite MDI V1

K203155510(k) TraditionalCleared Sep 17, 2021330-day reviewClass II21 CFR 868.5630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Breathesuite, Inc. · CAF Nebulizer (Direct Patient Interface)

Cleared on Sep 17, 2021 as substantially equivalent to K142516 (Reciprocal Labs Corporation, 2015) after a 330-day review. Its family tree reaches back 6 generations to 1982.

Decided
Sep 17, 2021
Review
330 days
Class
Class II
Product code
CAF
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K823423 (1982). 9 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK823423 Nebulizer Chronolog & InterpreterAdvanced Technology Products, Inc. · 1982
  2. 5 generations backK970344 Mdilog, Model MDC-511Medtrak Technologies, Inc. · 1997
  3. 4 generations backK091803 Smarttrack SystemNexus6, Ltd. · 2009
  4. 3 generations backK121609 Asthmapolis SystemReciprocal Labs Corporation · 2012
  5. 2 generations backK140638 Propeller System - Model 2Reciprocal Labs Corporation · 2014
  6. 1 generation backK142516 Propeller SystemReciprocal Labs Corporation · 2015
  7. This deviceK203155 BreatheSuite MDI V1Breathesuite, Inc. · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K823423Nebulizer Chronolog & InterpreterAdvanced Technology Products, Inc.1982—
−5K970344Mdilog, Model MDC-511Medtrak Technologies, Inc.1997—
−4K091803Smarttrack SystemNexus6, Ltd.2009—
−3K121609Asthmapolis SystemReciprocal Labs Corporation2012—
−2K140638Propeller System - Model 2Reciprocal Labs Corporation2014—
−1K142516Propeller SystemReciprocal Labs Corporation2015—
0 (this device)K203155BreatheSuite MDI V1Breathesuite, Inc.2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199420
199910
FIG. 1 — Lineage of K203155, 1982–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAF device

  1. #1 K260270 FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)score 13.2 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K142516Propeller System
Summary page 4
…Anesthesiology 5. Legally Marketed Predicate Device Primary Predicate Device: Propeller System Model 2 (K142516) Reference Predicate Device: CapMedic (K183586) 6. Device Description The Breathe…
Reciprocal Labs Corporation2015—
†K183586CapMedicCognita Labs, LLC2019—

Also cleared against K142516: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 39 years and passes through 5 companies; a new generation was cleared every 6.3 years on median.
  • None of the 9 ancestors has a recall.
  • 3 other devices also cite its predicate K142516.

How does its category compare?

All CAF devices

CAF Nebulizer (Direct Patient Interface): FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · CAF

7in 2025

2007: 182008: 122009: 82010: 102011: 102012: 92013: 92014: 92015: 82016: 52017: 82018: 92019: 32020: 62021: 82022: 42023: 82024: 42025: 72026 (partial year): 2
2007high 18 (2007) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAF

211in 2025

2007: 98 days median2008: 123 days median2009: 163 days median2010: 114 days median2011: 157 days median2012: 126 days median2013: 238 days median2014: 151 days median2015: 186 days median2016: 186 days median2017: 253 days median2018: 161 days median2019: 266 days median2020: 219 days median2021: 324 days median2022: 176 days median2023: 279 days median2024: 251 days median2025: 211 days median
2007high 324 (2021) · low 98 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAF

1in 2018

2007: 12011: 12014: 52015: 32016: 12017: 14, 13 Class I2018: 1
2007high 14 (2017) · low 0 (2008)2026

Class I (13 since 2007) Class II/III not classified

Adverse event reports per year · CAF

191in 2025

2007: 262008: 112009: 152010: 372011: 2372012: 1382013: 2172014: 1232015: 1662016: 2012017: 2562018: 1622019: 1852020: 1172021: 1612022: 552023: 1072024: 1022025: 191
2007high 256 (2017) · low 11 (2008)2025

MAUDE reports naming product code CAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071898126
200812123011
20098163015
201010114037
2011101571237
201291260138
201392380217
201491515123
201581863166
201651861201
2017825314 (13)256
201891611162
201932660185
202062190117
202183240161
20224176055
202382790107
202442510102
202572110191
20262—0—

What is it indicated for?

The BreatheSuite MDI Device is an electronic device intended for single-patient use of patients 5 years of age and older. It assists patients in recording and monitoring the actuations and technique of prescribed metered dose inhaler (MDI) usage. The BreatheSuite System is composed of the disposable, battery powered, portable BreatheSuite MDI Device and a mobile application. The BreatheSuite MDI Device is an accessory designed to work with an MDI by…

Read the full statement (291 words)

The BreatheSuite MDI Device is an electronic device intended for single-patient use of patients 5 years of age and older.

It assists patients in recording and monitoring the actuations and technique of prescribed metered dose inhaler (MDI)

usage. The BreatheSuite System is composed of the disposable, battery powered, portable BreatheSuite MDI Device and a

mobile application.

The BreatheSuite MDI Device is an accessory designed to work with an MDI by attaching to the top of the canister of the

inhaler. The BreatheSuite MDI Device does not interfere with regular MDI usage and can be removed and reattached with

ease. The BreatheSuite MDI Device does not actuate the inhaler but rather gathers information based on manual MDI

usage.

The BreatheSuite MDI Device measures the parameters of MDI use and records them for review by the patient. The

BreatheSuite application records, stores, and transmits usage events from the BreatheSuite MDI Device to a remote

storage system. Furthermore, BreatheSuite MDI reminds the patient of important steps of MDI use through visual

feedback in the BreatheSuite application.

The output of the BreatheSuite System is not intended to diagnose or replace a diagnosis provided by a licensed physician.

The BreatheSuite system is not intended for use as a MDI medication dose counter, nor is it intended to indicate the

quantity of medication remaining in an MDI. The BreatheSuite MDI Device is not intended to replace a physician's

advice or inhaler labels; patients are expected to always follow their doctor's advice and inhaler labels.

The BreatheSuite System can be used both indoors and outdoors as well as in home and work settings.

The BreatheSuite System may also be used in clinical trials where researchers need to know information about use of a

MDI Medication(s) by a participant.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K203155: BreatheSuite MDI V1.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K203155

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026